Japan Obesity Society warns against using diabetes drugs for dieting purposes

On the 3rd, the Japan Obesity Society published a recommendation calling for caution, stating that there have been reports of serious health problems that can lead to impaired consciousness during the weight loss process using drugs such as the diabetes treatment Manjaro (generic name tirzepatide). As prescriptions for dieting are becoming more and more popular at free medical clinics and other institutions, people are cautioning against weight loss that involves excessive dietary restrictions and carbohydrate restrictions.

According to the proposal, there have been a number of reports that people who use the drug for dieting purposes, rather than for medical purposes such as diabetes treatment, enter a state called ``ketosis,'' in which substances called ``ketone bodies'' increase in their blood, causing health problems.

As an example, a case was reported in which a woman in her 20s working in the hospitality industry was rushed to the hospital. Although the woman's body mass index (BMI) was 18.8, which was within the appropriate range (18.5 or more but less than 25.0), she was criticized by her workplace for being ``fat,'' so she used these drugs for an online medical treatment at her own expense. He continued to use the drug even though he continued to vomit, and his symptoms became so severe that he was rushed to hospital.

As ketosis progresses, the patient enters ``ketoacidosis,'' where the acidity of the blood increases, and in severe cases, there is a risk of unconsciousness.